Gender-specific care of the patient with diabetes: review and recommendations (Q28199679)

Europe PubMed Central

title

Gender-specific care of the patient with diabetes: review and recommendations (English)

0 references

1 reference

3

Robin Goland

0 references

author name string

Marianne J Legato

1

0 references

Andrea Gelzer

2

0 references

Susana A Ebner

4

0 references

Sabitha Rajan

5

0 references

Victor Villagra

6

0 references

Mark Kosowski

Evidence-based guidelines for cardiovascular disease prevention in women 11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, p

7

0 references

language of work or name

English

0 references

publication date

June 2006

0 references

published in

Gender Medicine

0 references

volume

3

0 references

issue

2

0 references

page(s)

131-58

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Hyperglycemia and cardiovascular disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The stages of type 1A diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Type 2 diabetes-a matter of beta-cell life and death?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Mitochondrial dysfunction and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Standards of medical care in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Vascular risk factors and diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Clinically apparent eating disorders in young diabetic women: associations with painful neuropathy and other complications

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

1 reference

7 January 2021

The continuing increase of diabetes in the US

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Type 2 diabetes in children and youth

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Cardiovascular risk factors emerge after artificial selection for low aerobic capacity

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Fetal and infant growth and impaired glucose tolerance at age 64.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Birthweight and the risk for type 2 diabetes mellitus in adult women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The fetal and childhood growth of persons who develop type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The function of leptin in nutrition, weight, and physiology

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Free fatty acids and pathogenesis of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes, obesity, and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Weight gain as a risk factor for clinical diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Adiposity as Compared with Physical Activity in Predicting Mortality among Women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Physical activity and risk for cardiovascular events in diabetic women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Physical activity and coronary heart disease in women: is "no pain, no gain" passé?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Relationship of Changes in Physical Activity and Mortality Among Older Women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Gender difference in the impact of type 2 diabetes on coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The Gender-Specific Impact of Diabetes and Myocardial Infarction at Baseline and During Follow-Up on Mortality From All Causes and Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Type II diabetes abrogates sex differences in endothelial function in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Coagulation Activation in Type 2 Diabetes Mellitus: the Higher Coronary Risk of Female Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes mellitus: a hypercoagulable state

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: A propensity analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Association of leisure time physical activity with the risk of coronary heart disease, hypertension and diabetes in middle-aged men and women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The prevalence of comorbid depression in adults with diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

17beta-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetic nephropathy is associated with decreased circulating estradiol levels and imbalance in the expression of renal estrogen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Reassessing the role of QTc in the diagnosis of autonomic failure among patients with diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Major congenital malformations after first-trimester exposure to ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Drug effects on the fetus and breast-fed infant

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Gestational diabetes: should it be added to the syndrome of insulin resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Increasing prevalence of Type II diabetes in American Indian children

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

1 reference

7 January 2021

Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Postmenopausal estrogens and risk of myocardial infarction in diabetic women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Women and heart disease: the role of diabetes and hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Risk factors that attenuate the female coronary disease advantage

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes and decline in heart disease mortality in US adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Cardiovascular disease in the diabetic woman

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes and cardiovascular risk factors: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes and Incidence of Functional Disability in Older Women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes mellitus as a contributor to the risk of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Dyslipidemia and ischemic heart disease mortality among men and women with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Hypertriglyceridemia as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Greater effect of diabetes on LDL size in women than in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

A Prospective Study of Walking as Compared with Vigorous Exercise in the Prevention of Coronary Heart Disease in Women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Rate of weight gain, weight fluctuation, and incidence of NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Oxidative stress and diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Estrogen Therapy and Risk of Cardiovascular Events Among Women With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes and Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Drug treatment of hyperlipidemia in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

C-reactive protein and risk of cardiovascular disease: evidence and clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Statins for Atherosclerosis — As Good as It Gets?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Meta-analysis of the effect of diabetes on restenosis rates among patients receiving coronary angioplasty stenting.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Comparison of short-term outcomes following coronary artery stenting in men versus women**The views expressed in this article are those of the authors and do not necessarily represent those of the Department of Veterans Affairs

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Gender and restenosis after coronary artery stenting.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Diabetes and coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

1 reference

7 January 2021

Is the use of insulin lispro safe in pregnancy?

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Intensive insulin therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Improving Quality of Care Through Disease Management

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling he

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Trends in complexity of diabetes care in the United States from 1991 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021

Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program

1 reference

https://api.crossref.org/works/10.1016%2FS1550-8579%2806%2980202-0

7 January 2021